Cancer therapy products make up 9% of medical journal ad pages through Q2 2014
There were more than 46,460 advertising pages purchased in medical journals through June 2014, a .2% decrease compared to 2013, according to Kantar Media. At the top of list are cancer therapy products, which continue to be first on the list in terms of pages and dollars. Antivirals, Other are currently fourth on this list. At the end of Q2 2013, this product class ranked 26th.
Top 5 Print Ad Drug Classes (Pages): June 2014
- Cancer Therapy Products – 4,325 pages (-8%)
- Diabetes Oral – 1,752 pages (+102%)
- Anticoagulants Oral – 1,287 pages (-39%)
- Antivirals Other – 1,026 pages (+340%)
- Biological Response Modifiers – 939 pages (+25%)
The percentage changes compare June 2014 to that same time period in 2013. For more information on these ad insights or other data, let one of us know.
Kantar Media sets the standard for accurate, comprehensive competitive advertising intelligence in the professional healthcare arena. Check back next month for updated data on the top products, classes, companies and category movers year-to-date.